Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of January 4, 2025 • 2:00 AM ET

Date/Time Source News Release
12/27/2024 10:00 PM EST TheNewsWire Universal Ibogaine Provides Bi-Weekly Default Status Report on Year-End Filings and Update on Belize Property Sale
12/12/2024 12:15 AM EST TheNewsWire Universal Ibogaine provides Bi-weekly Default Status Report on year-end filings and update on pending sale of Belize property
11/26/2024 07:00 AM EST TheNewsWire Universal Ibogaine advises of Offer to purchase Belize property and update on application for Management Cease Trade Order
11/19/2024 08:00 AM EST GlobeNewswire Impact BioMedical Inc. Issues Shareholder Letter Highlighting Recent Achievements and Strategic Vision
11/18/2024 08:00 PM EST TheNewsWire Universal Ibogaine Advises of Application for Management Cease Trade Order
10/15/2024 06:00 AM EDT GlobeNewswire Impact BioMedical Inc. Announces Issuance of Canadian Patent for Linebacker(TM) Technology Targeting Inflammatory Disease
10/07/2024 08:30 AM EDT GlobeNewswire Impact BioMedical Inc. (NYSE American: IBO) Announces IPO Participation with Strong Support from Partners and Affiliates
09/26/2024 08:30 AM EDT GlobeNewswire Impact BioMedical Inc. (NYSE: IBO) Announces 3F(TM) US Patent Issue
09/23/2024 08:00 AM EDT GlobeNewswire Impact BioMedical Inc. Introduces Leadership Team to Drive Innovation and Growth
09/17/2024 11:29 AM EDT GlobeNewswire Impact BioMedical Inc. Announces the Closing of its Initial Public Offering
Page

Additional News

As of January 4, 2025 • 2:00 AM ET

Date/Time Source News Release
12/01/2022 03:34 PM EST News Direct Universal Ibogaine Undertaking Offering of Convertible Debt Securities and Common Shares
12/01/2022 03:28 PM EST News Direct Universal Ibogaine Announces Closing of Private Placement
06/24/2022 03:43 PM EDT News Direct Nick Karos to Present at H.C. Wainwright 1st Annual Mental Health Conference
10/21/2021 08:00 PM EDT News Direct Universal Ibogaine Announces Engagement of Investor Relations Advisor
10/19/2021 03:54 PM EDT News Direct Universal Ibogaine Announces Enhancement of Board of Directors
10/05/2021 08:30 AM EDT News Direct Universal Ibogaine Commences Trading on the TSX-V
Page
  • 1